It targets the phosphorylated form of eIF4E (S209), resulting in the degradation of phosphorylated eIF4E to inhibit protein translation resulting in loss of proteins (Mcl-1 and c-Myc) required for the survival of leukemia cells [46]. This evidence concerns the gene EIF4E and leukemia.